bevacizumab

NDC product · U.S. Food and Drug Administration (openFDA) · United States

Product NDC 50242-059
Package NDC 50242-059-01
Package NDC 50242-059-02
SPL ID e695ff23-e9bf-4484-8b23-cf85a23ae8ab

What the source publishes

Labeler: Genentech, Inc.
Active ingredients: bevacizumab
Form: LIQUID
Administrative status: present-in-source-snapshot
Marketing status: DRUG FOR FURTHER PROCESSING
Product type: DRUG FOR FURTHER PROCESSING

Names this record is found by

bevacizumab

Complete source data

us:fda:ndc:50242-059_e695ff23-e9bf-4484-8b23-cf85a23ae8ab

{
  "name": "bevacizumab",
  "splId": "e695ff23-e9bf-4484-8b23-cf85a23ae8ab",
  "labels": [],
  "routes": [],
  "labeler": "Genentech, Inc.",
  "finished": false,
  "packaging": [
    {
      "description": "120 L in 1 TANK (50242-059-01)",
      "package_ndc": "50242-059-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "26-FEB-04"
    },
    {
      "description": "300 L in 1 TANK (50242-059-02)",
      "package_ndc": "50242-059-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "26-FEB-04"
    }
  ],
  "productId": "50242-059_e695ff23-e9bf-4484-8b23-cf85a23ae8ab",
  "useDomain": "unknown",
  "dosageForm": "LIQUID",
  "productNdc": "50242-059",
  "deaSchedule": null,
  "genericName": "bevacizumab",
  "productType": "DRUG FOR FURTHER PROCESSING",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BEVACIZUMAB",
      "strength": "25 g/L"
    }
  ],
  "applicationNumber": null,
  "marketingCategory": "DRUG FOR FURTHER PROCESSING",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20040226",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "unknown",
  "harmonizedIdentifiers": {},
  "listingExpirationDate": "20261231"
}

NDC Directory

U.S. Food and Drug Administration / openFDA

Retrieved: November 15, 2026
Licence: CC0 1.0
Source id: us.fda.ndc

Official source

What this source does not establish

Complete published endpoint, not a claim that FDA lists every medicine used in the US.
NDC listing, marketing category and application-number assertions are not proof of approval.
Tentative approval, discontinued products and historical submissions remain distinct.
Official document links only; linked documents have not been relicensed or mirrored.
No state restrictions, individual eligibility, or prescribing recommendations inferred.
UNII and RxNorm identifiers are source-asserted openFDA harmonization at record scope; arrays do not pair identifiers to individual products or ingredients, and are not GSID/PhPID or substitution evidence.

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

Get your free API key Read the reference

GET /v1/drugs/record

curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:50242-059_e695ff23-e9bf-4484-8b23-cf85a23ae8ab"